Shares of Cypress Bioscience Inc. (Nasdaq: CYPB) continued to rise after accepting Ramius' $6.50 per share cash acquisition offer by gaining 70 cents to $6.45.
Cypress Continues Rising
December 15, 2010 at 14:08 PM EST
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.